viernes, 23 de diciembre de 2022

PIONEER trial: favipiravir to treat moderate COVID-19 - The Lancet Respiratory Medicine

PIONEER trial: favipiravir to treat moderate COVID-19 - The Lancet Respiratory Medicine

No hay comentarios:

Publicar un comentario